Back to Beacon Pointe Advisors, LLC Beacon Pointe Advisors, LLC

IBRXIBRX
11 quarters

Position history for Beacon Pointe Advisors, LLCBeacon Pointe Advisors, LLC's holdings in IMMUNITYBIO INC

Beacon Pointe Advisors, LLC holds 40,227 shares of IBRX (IMMUNITYBIO INC), worth $308,542 as of 2026-Q1. The position was increased (+25.5% shares). IBRX represents 0.0% of Beacon Pointe Advisors, LLC's portfolio.

Current Value

$308,542

Current Shares

40,227

Total Value Change

+$264,531

Total Shares Change

+14,185

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
40,227
+25.5%
$308,5420.0%$10.00
29
2025-Q4
Decreased
32,046
-3.0%
$63,4520.0%$1.98
0
2025-Q3
Increased
33,042
+26.9%
$81,2840.0%$2.57
26
2025-Q2
Unchanged
26,042
0.0%
$68,7510.0%$2.70
0
2025-Q1
Unchanged
26,042
0.0%
$78,3860.0%$3.14
0
2024-Q4
Unchanged
26,042
0.0%
$66,6680.0%$2.68
0
2024-Q3
Unchanged
26,042
0.0%
$96,8760.0%$3.93
0
2024-Q2
Unchanged
26,042
0.0%
$164,5850.0%$6.32
0
2024-Q1
Unchanged
26,042
0.0%
$139,8460.0%$5.37
0
2023-Q4
Unchanged
26,042
0.0%
$130,7310.0%$5.02
0
2023-Q3
New
26,042
-
$44,0110.0%$1.69
28

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used